8-methanesulfonyl-3-(4-methylphenyl)-1,4,8-triazaspiro[4.5]dec-3-en-2-one

ID: ALA5280930

Max Phase: Preclinical

Molecular Formula: C15H19N3O3S

Molecular Weight: 321.40

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C2=NC3(CCN(S(C)(=O)=O)CC3)NC2=O)cc1

Standard InChI:  InChI=1S/C15H19N3O3S/c1-11-3-5-12(6-4-11)13-14(19)17-15(16-13)7-9-18(10-8-15)22(2,20)21/h3-6H,7-10H2,1-2H3,(H,17,19)

Standard InChI Key:  LNGYMRIIRWWFDF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   -0.1038   -0.8983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6106   -0.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -0.8983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3250   -1.7234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6106   -2.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1038   -1.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0392   -2.1357    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.7535   -1.7234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4560   -2.7189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4516   -2.8499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8180   -1.3107    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4364   -0.7397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1059   -0.0056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2822   -0.0978    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2330   -0.9532    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5183    0.7085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3431    0.7088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7535    1.4213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3410    2.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5204    2.1373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1041    1.4259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7534    2.8499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  4  7  1  0
  7  8  1  0
  7  9  2  0
  7 10  2  0
  1 11  1  0
 11 12  1  0
 12 13  1  0
 14 13  2  0
  1 14  1  0
 12 15  2  0
 16 13  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 20 19  1  0
 16 21  1  0
 21 20  2  0
 19 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5280930

    ---

Associated Targets(Human)

NEK2 Tchem Serine/threonine-protein kinase NEK2 (3514 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 321.40Molecular Weight (Monoisotopic): 321.1147AlogP: 0.67#Rotatable Bonds: 2
Polar Surface Area: 78.84Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.32CX Basic pKa: 0.42CX LogP: 1.16CX LogD: 1.15
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.87Np Likeness Score: -1.07

References

1. Bhuiyan AI, Choi AH, Ghoshal S, Adiele UA, Dana D, Choi JY, Fath KR, Talele TT, Pathak SK..  (2023)  Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening.,  88  [PMID:37094724] [10.1016/j.bmcl.2023.129288]

Source